We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

A First in Human Study of STT-5058, an Antibody That Binds ApoC3

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04419688
Recruitment Status : Terminated (recruitment failure)
First Posted : June 5, 2020
Last Update Posted : January 23, 2023
Information provided by (Responsible Party):
Staten Biotechnology BV

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : December 23, 2022
Actual Study Completion Date : December 23, 2022